AntenehATesfayeMD

Oncology • Washington, DC

Gastrointestinal Cancer

Attending Physician, Gastrointestinal and Neuroendocrine Oncology

Join to view full profile

Dr. Tesfaye is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Tesfaye's full profile

Already have an account?

Office
110 Irving St NW
Washington, DC 20010
Phone+1 202-877-6998

Fax+1 202-877-8909

Education & Training

MedStar Health/Georgetown University HospitalFellowship, Hematology and Medical Oncology, 2013 - 2016
McLaren Flint2013
McLaren Flint2009 - 2010
Gondar College of Medical SciencesClass of 2005, MD

Certifications & Licensure

DC State Medical License 2013 - 2024
MI State Medical License 2016 - 2023
VA State Medical License 2014 - 2016
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy Start of enrollment: 2022 Mar 24
Active, not recruiting
Phase 3
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer Start of enrollment: 2023 Aug 02
Recruiting
Phase 3
A Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer Start of enrollment: 2023 Apr 03
Recruiting
Phase 2
Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors Start of enrollment: 2020 Aug 06
Active, not recruiting
Phase 2
Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation Start of enrollment: 2022 Dec 08
Recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

Cancer survivor preferences on the timing and content of interventions to mitigate financial toxicity associated with cancer treatment.
Maisha R Huq, Marc D Schwartz, Heather Derry-Vick, Amanda Khoudary, Lia Sorgen
Supportive Care in Cancer. 2024-11-08
1 citations
Erratum: A randomized trial of combined PD-L1 and CTLA-4 inhibition with targeted low-dose or hypofractionated radiation for patients with metastatic colorectal cancer...
Arta M. Monjazeb, Anita Giobbie-Hurder, Ana Lako, Emily M. Thrash, Ryan C. Brennick
Clinical Cancer Research. 2021-09-01
12 citations
Clinical and functional characterization of atypical KRAS/NRAS mutations in metastatic colorectal cancer
Jonathan M. Loree, Yucai Wang, Muddassir A. Syed, Alexey V. Sorokin, Oluwadara Coker
Clinical Cancer Research. 2021-08-15

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American Medical Association - AMA
Member
American College of Physicians - ACP
Member